Clinical performance of artificial intelligence-powered annotation of tumor cell PD-L1 expression for treatment of immune-checkpoint inhibitor (ICI) in advanced non-small cell lung cancer (NSCLC).

被引：2
|
作者：
Kim, Hyojin
Choi, Sangjoon
Kim, Seokhwi
Aum, Jaehong
Pereira, Sergio
Park, Seonwook
Ma, Minuk
Shin, Seunghwan
Paeng, Kyunghyun
Yoo, Donggeun
Jung, Wonkyung
Ock, Chan-Young
Lee, Se-Hoon
Chung, Jin-haeng
Choi, Yoon-La
Mok, Tony S. K.
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[3] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
[4] Lunit Inc, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[6] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Med, Seoul, South Korea
[7] Chinese Univ Hong Kong, State Key Lab Translat Oncol, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9026
引用
收藏
页数：2
相关论文
共 50 条
  • [41] VALIDATION OF PD-L1 DYNAMIC EXPRESSION ON EXTRACELLULAR VESICLES AS A PREDICTOR OF RESPONSE TO IMMUNE-CHECKPOINT INHIBITORS AND SURVIVAL IN NON-SMALL CELL LUNG CANCER PATIENTS
    de Miguel Perez, Diego
    Barron, Feliciano
    Russo, Alessandro
    Lara-Mejia, Luis
    Gunasekaran, Muthukumar
    Cardona, Andres
    Peterson, Christine
    Colen, Rivka
    Naing, Aung
    Mack, Philip
    Hirsch, Fred
    Adamo, Vincenzo
    Arrieta, Oscar
    Rolfo, Christian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A25 - A26
  • [42] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [43] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [44] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [45] Plasma cell-free RNA PD-L1 expression and survival with immune checkpoint inhibitor-based treatment in advanced non-small-cell lung cancer
    Walker, Paul R.
    Jayananda, Sriraksha
    Pasli, Melisa
    Muzaffar, Mahvish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
    He, Jiabei
    Hu, Ying
    Hu, Mingming
    Li, Baolan
    SCIENTIFIC REPORTS, 2015, 5
  • [47] Characterization of PD-L1 expression in circulating tumor cells (CTCs) of non-small cell lung cancer (NSCLC) patients
    Krupa, R.
    Lu, D.
    Harvey, M.
    Louw, J.
    Jendrisak, A.
    Marrinucci, D.
    Dittamore, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 45 - 45
  • [48] Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
    Jiabei He
    Ying Hu
    Mingming Hu
    Baolan Li
    Scientific Reports, 5
  • [49] Evaluation of PD-L1/PD-1 on circulating tumor cells (CTCs) and on primary tumor in advanced non-small cell lung cancer (NSCLC)
    Kallergi, Galaktea
    Vetsika, Eleni Kyriaki
    Aggouraki, Despoina
    Lagoudaki, Eleni
    Koutsopoulos, Anastasios
    Koinis, Filippos
    Katsarlinos, Panagiotis
    Trypaki, Maria
    Stournaras, Christos
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    CANCER RESEARCH, 2017, 77
  • [50] Examination of PD-L1 and MHC Class I Expression in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Moore, Margaret
    Mills, Anne
    John, Melson
    Hall, Richard
    Gentzler, Ryan
    Stelow, Edward
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1126 - 1127
12345